1-172659342-ACCACCG-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000639.3(FASLG):c.153_158delGCCACC(p.Pro52_Pro53del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,610,614 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. P51P) has been classified as Likely benign.
Frequency
Consequence
NM_000639.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FASLG | NM_000639.3 | c.153_158delGCCACC | p.Pro52_Pro53del | disruptive_inframe_deletion | 1/4 | ENST00000367721.3 | NP_000630.1 | |
FASLG | NM_001302746.2 | c.153_158delGCCACC | p.Pro52_Pro53del | disruptive_inframe_deletion | 1/3 | NP_001289675.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASLG | ENST00000367721.3 | c.153_158delGCCACC | p.Pro52_Pro53del | disruptive_inframe_deletion | 1/4 | 1 | NM_000639.3 | ENSP00000356694.2 | ||
FASLG | ENST00000340030.4 | c.153_158delGCCACC | p.Pro52_Pro53del | disruptive_inframe_deletion | 1/3 | 1 | ENSP00000344739.3 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151750Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 244282Hom.: 0 AF XY: 0.00000754 AC XY: 1AN XY: 132564
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1458864Hom.: 0 AF XY: 0.0000179 AC XY: 13AN XY: 725636
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151750Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74110
ClinVar
Submissions by phenotype
Autoimmune lymphoproliferative syndrome type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 27, 2021 | This variant, c.153_158del, results in the deletion of 2 amino acid(s) of the FASLG protein (p.Pro52_Pro53del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs770888162, ExAC 0.02%). This variant has not been reported in the literature in individuals affected with FASLG-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at